These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24445273)

  • 1. 18F-FDG PET rarely provides additional information to 11C-methionine PET imaging in hyperparathyroidism.
    Chicklore S; Schulte KM; Talat N; Hubbard JG; O'Doherty M; Cook GJ
    Clin Nucl Med; 2014 Mar; 39(3):237-42. PubMed ID: 24445273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?
    Schalin-Jäntti C; Ryhänen E; Heiskanen I; Seppänen M; Arola J; Schildt J; Väisänen M; Nelimarkka L; Lisinen I; Aalto V; Nuutila P; Välimäki MJ
    J Nucl Med; 2013 May; 54(5):739-47. PubMed ID: 23554505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas.
    Feng Z; He D; Mao Z; Wang Z; Zhu Y; Zhang X; Wang H
    Clin Nucl Med; 2016 Mar; 41(3):e130-4. PubMed ID: 26646998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis between secondary and tertiary hyperparathyroidism in a case of a giant-cell and brown tumor containing mass. Findings by (99m)Tc-MDP, (18)F-FDG PET/CT and (99m)Tc-MIBI scans.
    Gedik GK; Ata O; Karabagli P; Sari O
    Hell J Nucl Med; 2014; 17(3):214-7. PubMed ID: 25397627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.
    Martínez-Rodríguez I; Martínez-Amador N; de Arcocha-Torres M; Quirce R; Ortega-Nava F; Ibáñez-Bravo S; Lavado-Pérez C; Bravo-Ferrer Z; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2014; 33(2):93-8. PubMed ID: 24125595
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Mathey C; Keyzer C; Blocklet D; Van Simaeys G; Trotta N; Lacroix S; Corvilain B; Goldman S; Moreno-Reyes R
    J Nucl Med; 2022 May; 63(5):785-791. PubMed ID: 34413141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging.
    Uslu-Beşli L; Sonmezoglu K; Teksoz S; Akgun E; Karayel E; Pehlivanoglu H; Khosroshahi BR; Ocak M; Kabasakal L; Sager S; Bukey Y
    Korean J Radiol; 2020 Feb; 21(2):236-247. PubMed ID: 31997599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.
    Traub-Weidinger T; Mayerhoefer ME; Koperek O; Mitterhauser M; Duan H; Karanikas G; Niederle B; Hoffmann M
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4199-205. PubMed ID: 25029418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomas.
    Herrmann K; Takei T; Kanegae K; Shiga T; Buck AK; Altomonte J; Schwaiger M; Schuster T; Nishijima K; Kuge Y; Tamaki N
    Mol Imaging Biol; 2009; 11(5):356-63. PubMed ID: 19340488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia.
    Hayakawa N; Nakamoto Y; Kurihara K; Yasoda A; Kanamoto N; Miura M; Inagaki N; Togashi K
    Nucl Med Commun; 2015 Jan; 36(1):53-9. PubMed ID: 25244350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
    Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET.
    Otto D; Boerner AR; Hofmann M; Brunkhorst T; Meyer GJ; Petrich T; Scheumann GF; Knapp WH
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1405-12. PubMed ID: 15278308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of parathyroid imaging: a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia.
    Oksüz MO; Dittmann H; Wicke C; Müssig K; Bares R; Pfannenberg C; Eschmann SM
    Diagn Interv Radiol; 2011 Dec; 17(4):297-307. PubMed ID: 21305468
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism.
    Braeuning U; Pfannenberg C; Gallwitz B; Teichmann R; Mueller M; Dittmann H; Reimold M; Bares R
    Nuklearmedizin; 2015; 54(1):26-30. PubMed ID: 25427653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PETC/CT with
    Bossert I; Chytiris S; Hodolic M; Croce L; Mansi L; Chiovato L; Mariani G; Trifirò G
    J Endocrinol Invest; 2019 Apr; 42(4):419-426. PubMed ID: 30094743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of combination [
    Wang Z; Feng Z; Zhu D; Wang X; Chen J; Zhu Y; Wang H
    BMC Endocr Disord; 2024 Feb; 24(1):19. PubMed ID: 38311763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?
    Weber T; Gottstein M; Schwenzer S; Beer A; Luster M
    World J Surg; 2017 Apr; 41(4):980-985. PubMed ID: 27834016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient with classic severe primary hyperparathyroidism in whom both Tc-99m MIBI scintigraphy and FDG-PET failed to detect the parathyroid tumor.
    Seki K; Hashimoto K; Hisada T; Maeda M; Satoh T; Uehara Y; Matsumoto H; Oyama T; Yamada M; Mori M
    Intern Med; 2004 Sep; 43(9):816-23. PubMed ID: 15497517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.